KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

ClearPoint Neuro (CLPT) Shares Issued (2018 - 2026)

ClearPoint Neuro's Shares Issued history spans 11 years, with the latest figure at $3.3 million for Q2 2025.

On a quarterly basis, Shares Issued rose 120.51% to $3.3 million in Q2 2025 year-over-year; TTM through Dec 2025 was $3.3 million, a 15438.1% increase, with the full-year FY2025 number at $3.3 million, up 15438.1% from a year prior.
Shares Issued hit $3.3 million in Q2 2025 for ClearPoint Neuro, up from -$267000.0 in the prior quarter.
Over the last five years, Shares Issued for CLPT hit a ceiling of $16.2 million in Q1 2024 and a floor of -$15.9 million in Q2 2024.
Historically, Shares Issued has averaged $352166.7 across 4 years, with a median of $117500.0 in 2021.
The widest YoY moves for Shares Issued: up 364.39% in 2021, down 99.14% in 2021.
Tracing CLPT's Shares Issued over 4 years: stood at -$119000.0 in 2021, then skyrocketed by 279.83% to $214000.0 in 2022, then tumbled by 224.77% to -$267000.0 in 2024, then soared by 1322.1% to $3.3 million in 2025.
Business Quant data shows Shares Issued for CLPT at $3.3 million in Q2 2025, -$267000.0 in Q3 2024, and -$15.9 million in Q2 2024.